[Comparison of the in vitro and in vivo kinetic parameters of solid sarcoma 180]

New biomarkers to predict the evolution of in situ breast cancers.

BioMed research international·2014

Reliability of a primary culture system to test cytotoxic drug activity in human-malignant melanoma.

International journal of oncology·2011

P53 and cathepsin-d are independent of established prognostic factors in breast-cancer.

International journal of oncology·2011

Relevance of cell kinetic and ploidy characteristics for the thermal response of malignant-melanoma primary cultures.

International journal of oncology·2011

Biological markers in transurethral biopsies from bladder-cancer - preliminary-results.

International journal of oncology·2011

Combined effects of lonidamine and tamoxifen in human breast-cancer cell-lines.

International journal of oncology·2011

Composite clinical scores in real-world extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy.

Tumori·2026

Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice.

Tumori·2026

Survival of carcinoid lung neuroendocrine tumours after surgical resection: A retrospective audit of 633 cases over 26 years.

Tumori·2026

Analysing workflows in radiation oncology: A process mining approach to identify treatment process challenges.

Tumori·2026

A radiomic approach to non-invasively decode tumor immune microenvironmental features in surgically resected non-small cell lung cancer.

Tumori·2026

When biological complexity demands more than better trial designs.

Tumori·2026

Density and treatment effect estimation under covariate-adaptive randomization with heavy-tailed outcomes.

Biometrics·2026

D-Flow SGLD: Source-Space Posterior Sampling for Scientific Inverse Problems with Flow Matching.

Journal of computational physics·2026

Bayesian two-sample survival probability curves with comparative summary measures and sensitivity analyses.

Contemporary clinical trials·2026

Analytically Continuing the Randomized Measurement Toolbox.

Physical review letters·2026

Shape-constrained semiparametric maximum likelihood for backward time under an accelerated failure time model.

Lifetime data analysis·2026

Doubly robust estimation of monotonic survival curves for time-varying treatments in observational studies.

The international journal of biostatistics·2026

Related Experiment Videos

[Comparison of the in vitro and in vivo kinetic parameters of solid sarcoma 180]

Related Concept Videos

New biomarkers to predict the evolution of in situ breast cancers.

Reliability of a primary culture system to test cytotoxic drug activity in human-malignant melanoma.

P53 and cathepsin-d are independent of established prognostic factors in breast-cancer.

Relevance of cell kinetic and ploidy characteristics for the thermal response of malignant-melanoma primary cultures.

Biological markers in transurethral biopsies from bladder-cancer - preliminary-results.

Combined effects of lonidamine and tamoxifen in human breast-cancer cell-lines.

Composite clinical scores in real-world extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy.

Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice.

Survival of carcinoid lung neuroendocrine tumours after surgical resection: A retrospective audit of 633 cases over 26 years.

Analysing workflows in radiation oncology: A process mining approach to identify treatment process challenges.

A radiomic approach to non-invasively decode tumor immune microenvironmental features in surgically resected non-small cell lung cancer.

When biological complexity demands more than better trial designs.

Density and treatment effect estimation under covariate-adaptive randomization with heavy-tailed outcomes.

D-Flow SGLD: Source-Space Posterior Sampling for Scientific Inverse Problems with Flow Matching.

Bayesian two-sample survival probability curves with comparative summary measures and sensitivity analyses.

Analytically Continuing the Randomized Measurement Toolbox.

Shape-constrained semiparametric maximum likelihood for backward time under an accelerated failure time model.

Doubly robust estimation of monotonic survival curves for time-varying treatments in observational studies.

Related Experiment Videos

[Comparison of the in vitro and in vivo kinetic parameters of solid sarcoma 180]

Related Concept Videos

Related Articles